Literature DB >> 1661258

The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction.

P M Lieberman1, A J Berk.   

Abstract

Eukaryotic transcriptional activators are believed to stimulate transcription through direct and/or indirect interactions with one or more of the general transcription factors. We show here that the Zta transcriptional activator protein encoded by the Epstein-Barr virus makes direct physical contact with the basic transcription factor TFIID. Both Zta and TFIID were expressed in and purified from Escherichia coli. Zta stabilized the binding of TFIID to Zta-responsive promoters as assayed by gel electrophoresis mobility-shift and immunoprecipitation of radiolabeled promoter DNA. A deletion mutant of Zta that failed to activate transcription failed to stabilize TFIID binding. DNase I footprinting showed that Zta reduced the dissociation rate of TFIID bound to the TATA element. Protein blotting and immunoprecipitation experiments demonstrated that TFIID and Zta also interact in the absence of promoter DNA. The amino acid residues 25-86 of Zta were essential for the stable association with TFIID and were shown to be required for trans-activation in vivo. We propose that Zta stimulates transcription, in part, by direct physical contact with the conserved domain of TFIID and the formation of a stable Zta-TFIID-promoter complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661258     DOI: 10.1101/gad.5.12b.2441

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  117 in total

1.  Inhibition of TATA-binding protein function by SAGA subunits Spt3 and Spt8 at Gcn4-activated promoters.

Authors:  R Belotserkovskaya; D E Sterner; M Deng; M H Sayre; P M Lieberman; S L Berger
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  The coactivator dTAF(II)110/hTAF(II)135 is sufficient to recruit a polymerase complex and activate basal transcription mediated by CREB.

Authors:  E A Felinski; P G Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

3.  Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation.

Authors:  L K Chang; S T Liu
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

4.  Functional binding of the "TATA" box binding component of transcription factor TFIID to the -30 region of TATA-less promoters.

Authors:  S R Wiley; R J Kraus; J E Mertz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

5.  The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.

Authors:  J M Hardwick; L Tse; N Applegren; J Nicholas; M A Veliuona
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

6.  The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor.

Authors:  S Zalani; E A Holley-Guthrie; D E Gutsch; S C Kenney
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

7.  Transcription factor IIA is inactivated during terminal differentiation of avian erythroid cells.

Authors:  J Bungert; R Waldschmidt; I Kober; K H Seifart
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  The ability to associate with activation domains in vitro is not required for the TATA box-binding protein to support activated transcription in vivo.

Authors:  W P Tansey; W Herr
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  The activation domain of GAL4 protein mediates cooperative promoter binding with general transcription factors in vivo.

Authors:  S Vashee; T Kodadek
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

10.  The bZIP domains of Fos and Jun mediate a physical association with the TATA box-binding protein.

Authors:  L J Ransone; L D Kerr; M J Schmitt; P Wamsley; I M Verma
Journal:  Gene Expr       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.